期刊文献+

肺炎克雷伯菌多黏菌素耐药机制研究 被引量:2

Molecular mechanism of colistin resistance in Klebsiella pneumoniae
原文传递
导出
摘要 目的 探讨肺炎克雷伯菌对多黏菌素的耐药机制.方法 对临床分离的3株多黏菌素耐药肺炎克雷伯菌(FK1149、FK1920和FK1934)和3株体外诱导多黏菌素耐药肺炎克雷伯菌(FK660R、FK713R和FK729R),通过PCR检测多黏菌素耐药相关基因,包括pmrAB、phoPQ、mgrB、crrAB、mcr-1和mcr-2;采用PROVEAN平台预测耐药相关蛋白质的生物功能改变情况;采用实时荧光定量PCR检测pmrH、pmrC、mgrB和phoP基因的相对表达量;SDS-PAGE银染试验检测3株临床分离的多黏菌素耐药菌株中是否存在脂多糖(LPS)缺失现象;同时通过接合转移试验检测是否存在耐药性转移的可移动性元件.结果 本研究检测到多黏菌素耐药株中存在PmrA(G53V)、PmrB(T157P和R256G)、MgrB(F44C)和CrrB(E189K)等多种有义突变,在FK713R和FK729R中分别检测到ISkpn14和IS5-like插入序列;所有耐药菌株中均未检测到mcr基因;与对照菌株相比,所有临床多黏菌素耐药菌株和诱导多黏菌素耐药菌株中pmrH和pmrC基因的表达量均增加,phoP和mgrB的表达水平也发生了变化;临床耐药株FK1149中存在LPS部分缺失.结论 本研究中,pmrAB或mgrB基因突变引起的LPS修饰是肺炎克雷伯菌对多黏菌素耐药的主要机制;首次在临床分离的肺炎克雷伯菌中检测到可能与多黏菌素耐药相关的PmrA(G53V)、MgrB(F44C)和CrrB(E189K)突变. Objective To investigate the molecular mechanism of colistin resistance in Klebsiella pneumoniae (K. pneumoniae ). Methods Three clinical isolates of eolistin-resistant K. pneumoniae (FKl149, FK1920 and FK1934) and three colistin-resistant mutants (FK660R, FK713R and FK729R) were investigated. Resistance genes of pmrAB, phoPQ, mgrB, crrAB, mcr-1 and mcr-2 were detected by PCR and then analyzed by sequencing. PROVEAN platform was used to predict changes in the biological functions of proteins related to drug resistance. Expression ofpmrH, pmrC, mgrB and phoP genes was meas- ured using quantitative real-time PCR. LPS silver staining and conjugation assay were performed to analyze the three clinical colistin-resistant isolates. Results Amino acid substitutions in PmrA (G53V), PmrB (T157P, R256G) , MgrB (F44C) and CrrB (E189K) were detected. ISkpnl4 and IS5-1ike insertion se- quences were detected in FK713R and FK729R, respectively. FK1149, FK1920 and FK1934 were negative for mcr genes. Compared with the wild-type strain, expression ofpmrH and pmrC genes at the transcriptional level was increased in all investigated isolates. Changes in the expression of phoP and mgrB genes were also observed. A partial deletion of LPS was identified in FK1149. Conclusion LPS modification induced by inactivation of PmrAB or MgrB is the main molecular mechanism of eolistin resistance in K. pneumoniae iso-lates in this study. Mutations in PmrA (G53V), MgrB (F44C) and CrrB (E189K) that might be related to colistin resistance are detected for the first time in clinical isolates of K. pneumoniae.
作者 林婕 侯渊博 卢鸿 曹建明 陈栎江 孙瑶 周铁丽 Lin Jie;Hou Yuanbo;Lu Hong;Cao Jianming;Chen Lijiang;Sun Yao;Zhou Tieli(Laboratory Medicine Center,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Chin;Clinical Laboratory,Sir Run Run Shaw Hospital,Hangzhou 310000,Chin;Department of Clinical Laboratory,Peace Hospital Affiliated to Changzhi Medical College,Changzhi 046000,Chin;School of Laboratory Medicine and Life Sciences,Wenzhou Medical University,Wenzhou 325000,China)
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2018年第8期605-610,共6页 Chinese Journal of Microbiology and Immunology
基金 “浙江省卫生高层次创新人才培养工程项目”资助浙卫发[2012]241号 温州市科技局(Y20170204)
关键词 多黏菌素 肺炎克雷伯菌 耐药机制 双组分调控系统 Colistin Klebsiella pneumoniae Drug resistance mechanism Two-component regulatory system
  • 相关文献

参考文献2

二级参考文献11

  • 1Biswas S, Brunel JM, Dubus JC, et at. Colistin: an update on the antibiotic of the 21 st century [ J]. Expert Rev Anti Infect Ther, 2012, 10(8) : 917-934.
  • 2Olaitan AO, Diene SM, Kempf M, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lap PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiologieal and molecular study [ J 3. Int J Antimierob Agents, 2014, 44(6): 500-507.
  • 3Jayol A, Nordmann P, Brink A, et al. Heteroresistance to colistin in Klebsiello pneumortiae associated with alterations in the PhoPQ regulatory system[ J]. Antimicrob Agents Chemother, 2015, 59 (5) : 2780-2784.
  • 4Jayol A, Poirel L, Brink A, et at. Resistance to colistin associated to a single amino acid change in protein PmrB among Klebsiella pneamoniae isolates of worldwide origin[J~. Antimicrob Agents Chemother, 2014, 58 (8) : 4762-4766.
  • 5Marchaim D, Chopra T, Pogue JM, et at. Outbreak of eolistin- resistant, carbapenem-resistant Klebsiella pneunmniae in metropolitan Detroit, Michigan [ J ]. Antimicrob Agents Chemother, 2011, 55 (2) : 593-599.
  • 6L6pez-Camacho E, G6mez-Gil R, Tobes R, et al. Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance~J]. J Antimicrob Chemother, 2014, 69 (3) : 632-636.
  • 7Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid- mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study[J], Lancet Infect Dis, 2016, 16(2) : 161-168.
  • 8Clinical and Laboratory Standards Institute. Performance standards for antimierobial susceptibility testing [ S ]. M100-$23. Wayne, PA: CLSI, 2013.
  • 9Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria[ J]. Front Microbiol, 2014, 5 : 643.
  • 10Cannatelli A, Giani T, D'Andrea MM, et at. MgrB Inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin E J 1. Antimicrob Agents Chemother, 2014, 58(10) : 5696-5703.

共引文献12

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部